Friday 8 June 2012

EmsPT survey reveals key challenges for Medical Device Manufacturers

Bringing new devices to market quickly is one of the main key challenges to manufacturers identified by EmsPT (a division of SolutionsPT) in a recent LinkedIN survey of 220 global medical device manufacturing representatives. 


43% of survey respondents noted that bringing innovative, cost effective devices to market efficiently were key to their overall strategy.

20% of those surveyed said that reducing overall cost of goods was their main challenge, while18% indicated that reducing the cost of compliance was a critical issue.The survey also revealed other areas of importance for medical device manufacturers including improving customer supply and satisfaction levels,  line extension and communication in the supply chain.

Steve McCluskey, Business Development Manager - Medical Device for EmsPT said “Our customers often mention that new device development is one of their greatest manufacturing challenges. This survey backs that theory up. It was also interesting to note that innovation is becoming increasingly important in the industry with it being critical to forward planning and operations”.

EmsPT has a detailed understanding of the medical device sector and supporting technologies and techniques that can be put into effect in a phased and controlled manner to deliver measurable business benefits. The EmsPT DRIVE program shows our working methodology and how this could be deployed to your benefit. Highly effective systems have been deployed which significantly reduce the increasingly difficult problems encountered in second year and beyond programs.

EmsPT Solutions –
  • The EmsPT DRIVE Program
  • MES (Manufacturing Execution Systems)
  • Performance Monitoring
  • Operations Management
  • Product Track and Trace (Traceability and Compliance)
  • Production Scheduling
  • Quality Management
If you would like for one of our consultants to discuss your individual business challenges contact us via www.emspt.co.uk

No comments:

Post a Comment